INTRODUCTION
Facilitative glucose transport in mammalian cells is mediated by a family of proteins comprised of at least five members, named GLUT 1-GLUT5 based on the order in which they were identified by cDNA cloning [1] [2] [3] [4] [5] [6] [7] [8] [9] . The GLUTI glucose transporter isoform, which is likely to be responsible for basal or constitutive glucose uptake [2] , was cloned from the human HepG2 cell line [1] , and its structure and function have been studied extensively [10] [11] [12] [13] [14] .
Facilitated glucose activity of GLUT1 is competitively inhibited by cytochalasin B [15] , which is expected to bind at or near the glucose-binding site of the transporter [16] . With u.v. irradiation, cytochalasin B is covalently inserted into glucose transporter molecules in a D-glucose inhibitable manner [17] [18] [19] . Proteolytic digestion experiments performed on the erythrocyte transporter have localized the cytochalasin B photolabelling site in the vicinity of transmembrane helix segments 10-11 [20, 21] . In addition, the wavelength needed for photolabelling is 280 nm, which suggests that the photolabelling proceeds via photoactivation of an aromatic amino acid residue on the transporter rather than the cytochalasin B molecule itself [22, 23] . These results lead to the hypothesis that the photolabelling site of GLUT1 is localized on either Trp-388 or Trp-412. Previously, the tryptophan residue in position 412 of GLUT1 was altered to leucine by site-directed mutagenesis to investigate the cytochalasin B photolabelling site. The photolabelling of this mutated GLUTI was not completely abolished, but labelling was decreased by 40 % compared with that of the wild-type GLUT 1 [24] .
By expressing a mutated glucose transporter, we found that amino acid substitution at Trp-388 reduces but does not abolish cytochalasin B photolabelling, whereas substitution of the amino acids at both Trp-388 and Trp-412 of GLUT1 completely abolishes this photolabelling.
previously for the Trp-412 mutant. Cytochalasin B labelling was finally abolished completely in the Trp-388, 412 mutant, while cytochalasin B binding to this mutant was decreased to approx. 30 % of that of the wild-type GLUTI at the concentration used for photolabelling. This level of binding is thought to be adequate to detect labelling, assuming that the labelling efficiency of these transporters is similar. These findings suggest that cytochalasin B binds to the transmembrane domain of the glucose transporter in the vicinity of helix 10-11, and is inserted covalently by photoactivation at either the 388 or the 412 site.
MATERIALS AND METHODS Expression of mutated glucose transporter
The single amino acid substitution of leucine for Trp-388 of GLUTI was performed as previously described [25] . In brief, the G to T point mutation was introduced at nucleotide 1286 of the wild-type rabbit GLUT1 glucose transporter cDNA by PCR [26] , using two synthesized oligonucleotides, 2230-2245 and 1255-1295, whose G at nucleotide 1286 had been replaced by T. This point mutation resulted in substitution of leucine (TTG) for tryptophan (TGG) at residue 388 of the encoded GLUTI glucose transporter (Trp-388 mutant).
In order to introduce two amino acid substitutions of leucines for Trp-388 and Trp-412, a two-step PCR was performed. First, using two synthesized oligonucleotides, 884-903 and 1351-1387 whose G at nucleotide 1358 had been substituted with T, the G to T point mutation was introduced at nucleotide 1358 of the wild-type glucose transporter cDNA. Similarly, the second G to T point mutation was introduced at nucleotide 1286 as described above. These two point mutations result in substitutions of leucine (TTG) for tryptophan (TGG) at residues 388 and 412 of the encoded GLUTI glucose transporter (Trp-388, 412 mutant).
These two fragments, prepared by PCR, as well as the ligation sites were sequenced and observed to have no mutations other than those at the desired nucleotides. The MaeI fragments of the mutated rabbit GLUTI glucose transporter cDNA (nucleotides 111-2230) were ligated into an expression vector termed pMTHneo and transfected into Chinese hamster ovary (CHO) cells by calcium phosphate precipitation as previously described [10] . Several cell lines were selected on the basis of their resistance to 600 /tg/ml of a neomycin derivative, G418 (Gibco), and were termed W388-L1 and W388-L2 (Trp-388 mutant) and W388,412-LI, W388,412-L2 (Trp-388, 412 mutant) in this study. 4 'C. The homogenates were centrifuged at 900 g for 10 min to sediment the fraction containing mainly nuclei and the resulting supernatant was centrifuged at 170000 g for 75 min at 4 'C. The pellet was subjected to SDS/(10 %) polyacrylamide gel electrophoresis and transferred on to a nitrocellulose filter. The filters were incubated with antisera raised against the synthesized peptide corresponding to residues 478-492 at a 1:40 dilution. The production and characterization of the antibody have been described previously [27] . The filters were then incubated with 251I-Protein A (Amersham) and subjected to autoradiography.
[3H]Cytochalasin B labelling
The membranes of CHO cells were prepared as described above. A 500 ,tg quantity of membranes was photoaffinity-labelled with 0.5 ,uM [3H]cytochalasin B in the presence of 20 ,uM unlabelled cytochalasin E as previously described [27] . The membranes were suspended in 1 % (w/v) SDS/50 mM dithiothreitol and electrophoresed on a 10% (w/v) polyacrylamide gel as described by Laemmli [28] . The gel lanes were sliced, solubilized with Protosol (DuPont-New England Nuclear), combined with a liquid-scintillation mixture (Econofluor, DuPont-New England Nuclear), and the radioactivity in each gel was determined.
[3H]Cytochalasin B binding
[3H]Cytochalasin B binding to the glucose transporter in the membrane was determined according to previously described methods with some modifications [29] . In brief, the membranes (2.5 4ug/,sl) were suspended in ice-cold TES buffer (10 mM Tris, 1 
Measurement of glucose uptake
Glucose uptake activity in CHO cells was determined by measuring the uptake of 2-deoxy-D-glucose, as previously described CHO cells in 24-well plates were incubated with indicated concentrations of 2-deoxy-D-[l,2-3H]glucose (ICN) for 3 min at 37 'C. The reaction was terminated by the addition of ice-cold Krebs-Ringer phosphate (KRP) buffer with 0.3 mM phloretin. The cells were washed and solubilized with 0.1 % Triton X-100 and the radioactivity was measured.
Cell surface labelling of glucose transporter Labelling of cell-surface glycoproteins was performed according to previously described methods [31] with some modifications. The CHO cells in the culture dish (diameter 60mm) were incubated with 1 unit/ml of neuraminidase at 22 'C in PBS, pH 6.0, for 15 min. The following procedures for labelling were performed at 15 'C. The cells were pre-reduced with 2 mM sodium borohydride in PBS, pH 8.0, for 5 min. They were incubated with 40 units/ml of galactose oxidase in PBS, pH 7.4, for 30 min and then reduced with sodium borotritide (1 mCi) in 1 ml of PBS, pH 8.0. After 10 min, 1 ml of PBS, pH 7.4, was added and the cells were incubated for another 5 min, then washed and solubilized with 2% dodecyl octaethyleneglycol ether (C12E8) in 50 mM Hepes/ 150 mM NaCl, pH 7.6, containing 1 mM phenylmethanesulphonyl fluoride. The cell lysate was centrifuged at 13000 g for 30 min at 4 'C. The labelled glucose transporter in the supernatant (200 1,) was immunoprecipitated with 6 ,g of anti-peptide antibody raised against the C-terminal domain (residues 478-492) and 25 ,l of Protein A Cellulofine. The immunoprecipitates were suspended with 2% (w/v) SDS (lauryl grade, Pierce), 20 mM dithiothreitol and 6 M urea and then subjected to SDS/(l0 %) polyacrylamide gel electrophoresis. The gel lanes were sliced and the incorporated 3H in each gel slice was determined as previously described [27] .
RESULTS
The Trp-388 mutated glucose transporter protein was expressed, as shown in lanes 3 and 4 of Figure 1 (a). Western blotting of two stable transfectants (clones W388-LI and W388-L2) with an anti-peptide antibody directed against the C-terminal domain (residues 478-492) of GLUT1 revealed significant quantities of the expressed 50000-Mr glucose transporter in these cells. Only a small amount of endogenous GLUT1 is observed in parental CHO cells (Figure 1, lane 1 [10] . Near confluent monolayers of were photoaffinity-labelled with 0.5 ,uM [3H]cytochalasin B as described previously [27] and were subjected to SDS/(10%) polyacrylamide gel electrophoresis. The gel lanes were sliced, solubilized with Protosol, and the radioactivity in each gel slice was determined. These experiments were repeated three times, with similar results. Control CHO (A), clone C (0), clone D (A), clone W388,412-L1 (0), clone W388,412-L2 (]). revealed significant expression of the 50000-Mr glucose transporter in these cells, as shown in lanes 2 and 3 of Figure 2(a) . Two clones expressing a large amount of the wild-type GLUTI, which were prepared as previously described, were also studied. The quantities of the wild-type GLUTI expressed in these clones, termed clones D and C, are shown in Figure 2 (lanes 4 and 5 respectively). The expression of mutated GLUTI in clone W388,412-L1 (Figure 2, lane 2) was two-thirds that of the wildtype GLUT1 in clone C (Figure 2, lane 5 Figure 4 Cell-surface labelling of the expressed GLUT1 protein in CHO cells with galactose oxidase and borotritide Cell-surface glycoproteins were labelled, using previously described methods, with some modifications. The CHO cells were incubated with 1 unit/ml of neuraminidase at 22°C in PBS, values of these membranes for cytochalasin B were 24 and 13 pmol/mg of membrane protein respectively. After correcting differences in the amounts of glucose transporter expressed, the number of apparent binding sites on the Another possibility is that some of the mutated glucose transporters were not inserted into membranes in an appropriate manner, which prevented cytochalasin B binding to these transporters.
To estimate the amounts of wild-type and mutated glucose transporters on the cell surface, cell-surface glycoproteins of clone C and clone W388,412-L1 were labelled in intact cells by oxidation with galactose oxidase and subsequent reduction with borotritide ( Figure 4) . The amount of labelled 50000Mr protein in clone W388,412-L1, which was specifically immunoprecipitated with an antibody against the C-terminal domain ofGLUT1, was approx. 55 % of that in clone C. Taking into account the difference in the amounts of glucose transporter expressed, the relative distribution of the glucose transporter on the plasma membrane was slightly decreased in the mutated GLUT 1 glucose transporter compared with the wild-type transporter. Labelling was barely detectable in control CHO cells. These results indicate that insertion of the Trp-388, 412 mutant into the plasma membrane was similar to that of the wild-type GLUT1 protein, although a slight decrease in plasma membrane targeting was observed.
Transporter function of the expressed GLUTI was assessed by uptake of 1 mM 2-deoxy-D-glucose and is shown in Table 2 . Expression ofthe wild-type GLUT1 resulted in a marked increase (approx. 5-fold) in transport activity, as compared with control CHO cells. In contrast, only a small increase in the uptake of 2-deoxy-D-glucose was observed in clones W388,412-LI and W388,412-L2. Although the increases observed in clones W388,412-Ll and W388,412-L2 were small, transport activity was consistently greater than that observed in control CHO cells when glucose uptake measurements were performed in parallel in these clones. In addition, the increase in clone W388,412-L2 was smaller than that in clone W388,412-LI, probably due to differences in the amounts of mutant glucose transporter expressed between these two clones. Taking into account these differences in expressed amounts and plasma membrane distribution, the glucose transport activity of the Trp-388, 412 mutant was estimated to be decreased to approx. 30 % of that of wild-type GLUTI. Consistent with the results that cytochalasin B binds to the Trp-388, 412 mutant glucose transporter, 2-deoxy-D-glucose uptake was inhibited by cytochalasin B in clone W388,412-LI ( Figure 5 ). The results of 2-deoxy-D-glucose uptake by clone C and clone W388,412-L1 were corrected for uptake by parental CHO photolabelling is schematically represented in Figure 6 . This proposal is not inconsistent with previous results obtained by cleavage of the photolabelled glucose transporter with Nbromosuccinimide [20] . Although it was concluded that the labelled 3000-Mr fragment was composed of residues 388-412 [20] , this fragment must be comprised of residues 389-412 only [21] , because N-bromosuccinimide cleaves at the C-terminal side of tryptophan [32] . However, its assignment to residues 364-388 is another possibility, which seems to have been dismissed in previous reports [20] [24, 25] . These results suggest that one tryptophan residue, either at 388 or 412, is necessary to maintain a high affinity for cytochalasin B.
Glucose transport activity of the Trp-388, 412 mutant was markedly (by 70%) diminished. Similar marked decreases in glucose transporter activity were also observed in the Trp-412 [24] and the Trp-388 mutants [25] . Thus introduction of two mutations in Trp-388 and Trp-412 did not further affect transport activity compared with a single mutation at 388 or 412 position. These results further suggest that the domain responsible for glucose transport and that for cytochalasin B binding are not identical in the GLUT 1 glucose transporter. Garcia et al. recently reported that the reduced activity of the Trp-388 mutant expressed in Xenopus oocytes resulted from the decreased targeting of plasma membranes and a modest decrease in intrinsic activity, whereas the reduced transport activity of the Trp-412 mutant was due entirely to a decrease in the intrinsic activity of mutant proteins [33] . The Trp-388, 412 mutant expressed in CHO cells appeared to exhibit features of both the Trp-388 mutant and the Trp-412 mutant expressed in Xenopus oocytes. However, the Trp-388 mutant expressed in CHO cells was observed to target plasma membranes in a manner similar to that of wild-type GLUT1 [25] , a result different from that in Xenopus oocytes, suggesting that targeting machinery differs between Xenopus oocytes and CHO cells.
In conclusion, taken together with the previous results of proteolytic digestion of labelled transporter [20, 21] , the wavelength needed for photolabelling [22, 23] , and decreased cytochalasin B labelling in the Trp-412 mutant [24] , our present data indicate that Trp-388 and Trp-412 play important roles in cytochalasin B binding to the glucose transporter and that these two tryptophan residues are likely to be the two putative cytochalasin B labelling sites on GLUT1 protein. However, further studies, such as direct sequencing of tryptic peptides, are required to obtain some experimental verification.
